Innovation

We bring our antibody engineering expertise to pioneering researchers with the intent to advance immunology breakthroughs into differentiated medicines for patients.

Through collaboration, we have a common purpose and can accelerate discovery processes to bring solutions to patients who need them.

We know that together we are better.

Innovation and co-creation are at the core of our strategy. We integrate our unique antibody engineering capabilities with the deep disease and target biology expertise of our collaborators. By innovating at the discovery level, we have built a broad pipeline of differentiated potential immunology solutions to offer patients.

We innovate at both the variable region or V region (where antigens and foreign proteins are recognized) and the constant region or Fc region (where antibodies modulate other cells in the immune system):

"Stepping into these strategic, academic, industry collaborations. This is a wonderful
ecosystem that we are creating, by bringing that expertise together."

— Prof. Bart Lambrecht